2026 Mazda CX-6e Review: Can Mazda’s electric SUV take on the Tesla Model Y, BYD Sealion 7 and the rest and win?
Compiled by ADME Newsroom from 3 sources
First reported by EV Central ·

Image: EV Central
The quick read
Full coverage
2026 Mazda CX-6e Review: Can Mazda’s electric SUV take on the Tesla Model Y, BYD Sealion 7 and the rest and win?
Mazda is finally getting serious about EVs, and here’s the proof. The CX-6e. The CX-6e is Mazda’s first mainstream electric The post 2026 Mazda CX-6e Review: Can Mazda’s electric SUV take on the…
Read at EV Central →Made-in-China Mazda CX-6e EV could outsell CX-5 as it rivals BYD Sealion 7, Tesla Model Y, Zeekr 7X
In a dramatic shift for the Japanese carmaker, Mazda says the electric CX-6e could become its number one seller in Australia — providing regulatory and economic conditions don’t change too…
Read at Chasing Cars →Mazda CX-6e review 2026 Australia: Should Zeekr 7X & Tesla Model Y be worried by the stylish new EV?
Andrew Chesterton reviews the 2026 Mazda CX-6e, the brand's first mainstream electric SUV in Australia. It arrives in two grades, the entry-level GT from $53,990 and the flagship Azami from $56,990,…
Watch at CarsGuide →More from the newsroom
How long Chinese auto brands have been in Australia
2026 Porsche Cayenne Turbo EV Brief Drive: This vehicle is brilliant, but all sorts of wrong
BYD’s smallest EV, the Racco, heads to new international markets
Tesla lowers in-stock Model 3 prices by $2,750
New Volkswagen ID. Tiguan likely for Australia, revealed as complete replacement for ID.4 and ID.5 electric SUVs
GWM Cannon Hi4-T PHEV: Sydney to Melbourne Road Trip
The ADME Newsroom is a news aggregator. Headlines, excerpts and article images remain the property of their original publishers, are shown for the purpose of reporting news, and always link to and credit the original reporting. Items marked “file image” use manufacturer-supplied press imagery of the vehicle referenced; vehicle and brand names are trademarks of their respective owners.
Quick-read summaries and “ADME commentary” are our own, are clearly marked, and are general industry commentary — not financial, legal or purchasing advice. Summaries and commentary may be AI-assisted and can contain errors — always check the original reporting before relying on specifics. Publishers and manufacturers: for corrections, attribution changes or removal, contact advertising@adme.net.au and we'll action it promptly. Read our editorial standards.